Cancer
Recent news:
Professor Derfogail Delcassian has been awarded $1 million in non-dilutive seed funding to accelerate the commercialization of her work on targeted molecular therapies for hard-to-treat cancers.
Pulse 2.0 interviewed MTM alumnus Sungwon Lim, founder of ImpriMed, a company that provides personalized medicine for pets with blood cancer diseases.
How isochoric preservation can protect food, organs — and even the planet. Professor Boris Rubinsky discusses the state of the art in cryogenics and preservation.
Congratulations to Professor Phillip Messersmith, a recipient of the 2023 Bakar Fellows Spark Award for his work on gel protection during tumor ablation. The award is designed to accelerate faculty-led research and produce tangible, positive societal impact through commercialization.
Undergraduate bioengineering student Alexandra Potter has been a long-term collaborator with Dr. CJ Yang of Harvard University on the effectiveness of lung cancer screening. Today she is first author on a paper published in the British Medical Journal, “Association of computed tomography screening with lung cancer stage shift and survival in the United States.” Potter is also CEO of the American Lung Cancer Screening Initiative.